| mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-07 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
6e-07 |
| mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-07 |
| mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
| mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-06 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
6e-06 |
| mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-06 |
| mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
8e-06 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |